We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04795141
Recruitment Status : Terminated (The sponsor's development strategy is adjusted.)
First Posted : March 12, 2021
Last Update Posted : September 22, 2022
Information provided by (Responsible Party):
Inmagene Biopharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 11, 2022
Actual Study Completion Date : August 30, 2022